Literature DB >> 15723228

Tolerance to nicotine in mice lacking alpha7 nicotinic receptors.

C Naylor1, D Quarta, C Fernandes, I P Stolerman.   

Abstract

RATIONALE: Previous studies have suggested that a knockout of the gene coding for alpha7 nicotinic receptor subunits influences the behaviour of undrugged mice but not the acute effect of nicotine on locomotor activity.
OBJECTIVES: The present studies extend these observations to nicotine tolerance assessed by means of schedule-controlled behaviour.
METHODS: Groups of alpha7-/- and alpha7+/+ mice were trained to press levers under an FR20 schedule of food reinforcement. The acute response rate-depressant effects of nicotine were determined in both genotypes and the mice were then subdivided into groups treated daily with nicotine (1.2 mg/kg/day) or saline. After 39 days of exposure to this regimen, the dose-response curves were re-determined.
RESULTS: Knockout of the alpha7 gene had no consistent effect on the lever-pressing behaviour of undrugged mice and did not influence the acute, dose-related, response rate-depressant effect of nicotine (0.2-1.2 mg/kg). When dose-response curves for nicotine (0.4-2.0 mg/kg) were re-determined after daily dosing with the drug, both wild-type and knockout mice developed similar tolerance to nicotine, as shown by approximately 2.5-fold shifts to the right of the dose-response curves.
CONCLUSIONS: Nicotinic receptors containing the alpha7 subunit do not play a significant role in the regulation of the lever-pressing behaviour studied or in the acute behavioural depressant effect of nicotine and the development of tolerance to that effect. Such results contrast with previous reports suggesting profound impairments in sensitivity to nicotine in nicotinic receptor beta2-/- mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723228     DOI: 10.1007/s00213-005-2187-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

1.  Acute and chronic tolerance to nicotine measured by activity in rats.

Authors:  I P Stolerman; R Fink; M E Jarvik
Journal:  Psychopharmacologia       Date:  1973-06-29

2.  Nicotine tolerance in rats; role of dose and dose interval.

Authors:  I P Stolerman; P Bunker; M E Jarvik
Journal:  Psychopharmacologia       Date:  1974-02-06

3.  Characterization and modulation of acute tolerance to nicotine in mice.

Authors:  M I Damaj; S P Welch; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1996-04       Impact factor: 4.030

4.  The development of pharmacological tolerance to the effect of nicotine on schedule-controlled responding in mice.

Authors:  J S Hendry; J A Rosecrans
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

5.  The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat.

Authors:  A Markou; N E Paterson
Journal:  Nicotine Tob Res       Date:  2001-11       Impact factor: 4.244

6.  Long-term potentiation of excitatory inputs to brain reward areas by nicotine.

Authors:  H D Mansvelder; D S McGehee
Journal:  Neuron       Date:  2000-08       Impact factor: 17.173

7.  Antagonism of the discriminative and aversive stimulus properties of nicotine in C57BL/6J mice.

Authors:  J Gommans; I P Stolerman; M Shoaib
Journal:  Neuropharmacology       Date:  2000-10       Impact factor: 5.250

8.  The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion.

Authors:  M Shoaib; J Gommans; A Morley; I P Stolerman; R Grailhe; J-P Changeux
Journal:  Neuropharmacology       Date:  2002-03       Impact factor: 5.250

9.  Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine.

Authors:  A J Grottick; G Trube; W A Corrigall; J Huwyler; P Malherbe; R Wyler; G A Higgins
Journal:  J Pharmacol Exp Ther       Date:  2000-09       Impact factor: 4.030

10.  Conditioned tolerance to the anorectic and corticosterone-elevating effects of nicotine.

Authors:  A R Caggiula; L H Epstein; S M Antelman; S S Saylor; K A Perkins; S Knopf; R Stiller
Journal:  Pharmacol Biochem Behav       Date:  1991-09       Impact factor: 3.533

View more
  14 in total

1.  The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.

Authors:  Colin S Cunningham; Lance R McMahon
Journal:  Eur J Pharmacol       Date:  2010-12-21       Impact factor: 4.432

Review 2.  Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

Authors:  F Scott Hall; Athina Markou; Edward D Levin; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

3.  Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice.

Authors:  Astrid K Stoker; Berend Olivier; Athina Markou
Journal:  Behav Genet       Date:  2011-10-19       Impact factor: 2.805

Review 4.  Negative affective states and cognitive impairments in nicotine dependence.

Authors:  F Scott Hall; Andre Der-Avakian; Thomas J Gould; Athina Markou; Mohammed Shoaib; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-06-06       Impact factor: 8.989

5.  Gestational exposure to perfluorooctanoic acid (PFOA): Alterations in motor related behaviors.

Authors:  David R Goulding; Sally S White; Sandra J McBride; Suzanne E Fenton; G Jean Harry
Journal:  Neurotoxicology       Date:  2016-11-22       Impact factor: 4.294

Review 6.  Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice.

Authors:  Christie D Fowler; Michael A Arends; Paul J Kenny
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

Review 7.  Insights into the neurobiology of the nicotinic cholinergic system and nicotine addiction from mice expressing nicotinic receptors harboring gain-of-function mutations.

Authors:  Ryan M Drenan; Henry A Lester
Journal:  Pharmacol Rev       Date:  2012-08-10       Impact factor: 25.468

8.  Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the alpha7 nicotinic acetylcholine receptor subunit.

Authors:  Ramiro Salas; Adam Main; David Gangitano; Mariella De Biasi
Journal:  Neuropharmacology       Date:  2007-09-02       Impact factor: 5.250

Review 9.  Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research.

Authors:  George S Portugal; Thomas J Gould
Journal:  Behav Brain Res       Date:  2008-05-16       Impact factor: 3.332

10.  Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine release.

Authors:  Davide Quarta; Christopher G Naylor; Jacques Barik; Cathy Fernandes; Susan Wonnacott; Ian P Stolerman
Journal:  Psychopharmacology (Berl)       Date:  2008-08-30       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.